In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

immunomodulatory agent CC-11006 
A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines. Check for active clinical trials or closed clinical trials using this agent.
Code names:CC-11006
CC-11006-MDS-001